NO994928D0 - Fremgangsmaate ved fremstilling av enkelt-enantiomer narwedine - Google Patents
Fremgangsmaate ved fremstilling av enkelt-enantiomer narwedineInfo
- Publication number
- NO994928D0 NO994928D0 NO994928A NO994928A NO994928D0 NO 994928 D0 NO994928 D0 NO 994928D0 NO 994928 A NO994928 A NO 994928A NO 994928 A NO994928 A NO 994928A NO 994928 D0 NO994928 D0 NO 994928D0
- Authority
- NO
- Norway
- Prior art keywords
- narwedine
- preparation
- enantiomer
- procedure
- solvent
- Prior art date
Links
- QENVUHCAYXAROT-UHFFFAOYSA-N Galanthaminon Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(=O)C=C2 QENVUHCAYXAROT-UHFFFAOYSA-N 0.000 title abstract 4
- QENVUHCAYXAROT-YOEHRIQHSA-N Narwedine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1CC(=O)C=C2 QENVUHCAYXAROT-YOEHRIQHSA-N 0.000 title abstract 4
- WCRYNEMFWLZAAZ-WMLDXEAASA-N Narwedine Natural products COc1ccc2CCCC[C@@]34C=CC(=O)C[C@@H]3Oc1c24 WCRYNEMFWLZAAZ-WMLDXEAASA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 238000010899 nucleation Methods 0.000 abstract 1
- VMXUWOKSQNHOCA-UKTHLTGXSA-N ranitidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-UKTHLTGXSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9707413.2A GB9707413D0 (en) | 1997-04-11 | 1997-04-11 | Process |
| PCT/GB1998/001029 WO1998046610A1 (en) | 1997-04-11 | 1998-04-08 | Process for preparing single enantiomer narwedine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO994928L NO994928L (no) | 1999-10-08 |
| NO994928D0 true NO994928D0 (no) | 1999-10-08 |
| NO325949B1 NO325949B1 (no) | 2008-08-25 |
Family
ID=10810680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19994928A NO325949B1 (no) | 1997-04-11 | 1999-10-08 | Fremgangsmate ved fremstilling av hovedsakelig enkelt-enantiomer narwedin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6392038B1 (no) |
| EP (1) | EP0971930B1 (no) |
| JP (1) | JP4322317B2 (no) |
| KR (1) | KR100523125B1 (no) |
| AT (1) | ATE253579T1 (no) |
| AU (1) | AU726812B2 (no) |
| CA (1) | CA2284976C (no) |
| DE (1) | DE69819479T2 (no) |
| DK (1) | DK0971930T3 (no) |
| ES (1) | ES2209125T3 (no) |
| GB (1) | GB9707413D0 (no) |
| NO (1) | NO325949B1 (no) |
| NZ (1) | NZ337962A (no) |
| PT (1) | PT971930E (no) |
| WO (1) | WO1998046610A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1670767B2 (en) * | 2003-09-26 | 2014-10-29 | ScinoPharm Taiwan, Ltd. | Resolution of a narwedine amide derivative |
| US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
| WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
| WO2006018703A2 (en) * | 2004-08-16 | 2006-02-23 | Ranbaxy Laboratories Limited | Processes for preparation of narwedine and its use in the synthesis of galantamine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
| PL184590B1 (pl) * | 1994-10-21 | 2002-11-29 | Sanochemia Pharmazeutika Ag | Sposób wytwarzania pochodnych a heksahydro H benzofuro[ a ef][ ] benzoazepiny sposób odbromowania tych pochodnych sposób wytwarzania związków typu N demetylobromo i epibromo galantaminy oraz nowe związki z określonego zbioru |
-
1997
- 1997-04-11 GB GBGB9707413.2A patent/GB9707413D0/en active Pending
-
1998
- 1998-04-08 WO PCT/GB1998/001029 patent/WO1998046610A1/en not_active Ceased
- 1998-04-08 KR KR10-1999-7009195A patent/KR100523125B1/ko not_active Expired - Lifetime
- 1998-04-08 AU AU69296/98A patent/AU726812B2/en not_active Expired
- 1998-04-08 DE DE69819479T patent/DE69819479T2/de not_active Expired - Lifetime
- 1998-04-08 EP EP98915005A patent/EP0971930B1/en not_active Expired - Lifetime
- 1998-04-08 US US09/402,722 patent/US6392038B1/en not_active Expired - Lifetime
- 1998-04-08 NZ NZ337962A patent/NZ337962A/en not_active IP Right Cessation
- 1998-04-08 PT PT98915005T patent/PT971930E/pt unknown
- 1998-04-08 DK DK98915005T patent/DK0971930T3/da active
- 1998-04-08 ES ES98915005T patent/ES2209125T3/es not_active Expired - Lifetime
- 1998-04-08 JP JP54359598A patent/JP4322317B2/ja not_active Expired - Lifetime
- 1998-04-08 CA CA002284976A patent/CA2284976C/en not_active Expired - Lifetime
- 1998-04-08 AT AT98915005T patent/ATE253579T1/de active
-
1999
- 1999-10-08 NO NO19994928A patent/NO325949B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010006117A (ko) | 2001-01-26 |
| ATE253579T1 (de) | 2003-11-15 |
| CA2284976C (en) | 2006-10-17 |
| ES2209125T3 (es) | 2004-06-16 |
| WO1998046610A1 (en) | 1998-10-22 |
| KR100523125B1 (ko) | 2005-10-19 |
| GB9707413D0 (en) | 1997-05-28 |
| EP0971930B1 (en) | 2003-11-05 |
| JP2001518911A (ja) | 2001-10-16 |
| DE69819479D1 (de) | 2003-12-11 |
| AU726812B2 (en) | 2000-11-23 |
| CA2284976A1 (en) | 1998-10-22 |
| AU6929698A (en) | 1998-11-11 |
| NZ337962A (en) | 2001-05-25 |
| US6392038B1 (en) | 2002-05-21 |
| PT971930E (pt) | 2004-02-27 |
| EP0971930A1 (en) | 2000-01-19 |
| DK0971930T3 (da) | 2004-01-26 |
| NO994928L (no) | 1999-10-08 |
| JP4322317B2 (ja) | 2009-08-26 |
| NO325949B1 (no) | 2008-08-25 |
| DE69819479T2 (de) | 2004-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0960109T3 (da) | Fremgangsmåde til fremstilling af tolterodin | |
| ES2133769T3 (es) | Procedimiento para la sintesis diastereoselectiva de analogos de nucleosidos. | |
| ATE240139T1 (de) | Co-kristallisationsprozess | |
| IN184142B (no) | ||
| BR0002073A (pt) | Processo para a preparação de um composto quiral | |
| NO994928D0 (no) | Fremgangsmaate ved fremstilling av enkelt-enantiomer narwedine | |
| BR9611683A (pt) | Processo para a preparação de compostos | |
| IT1293777B1 (it) | Processo per la preparazione di tetraazamacrocicli | |
| ATE183995T1 (de) | Herstellung von mit enantiomer angereicherten ortho-substituierten alpha, alpha-diaromatischen methanolen | |
| BR9810685B1 (pt) | processo para a prepraração de um composto. | |
| BR9807785A (pt) | Processo para a preparação do composto, e, composto | |
| ES2071653T3 (es) | Procedimiento para preparar beta-2',2'-difluornucleosidos. | |
| BR9909627A (pt) | Processo para a produção de r-(+)-6-carboxiamido-3-n-metila-mino-1,2,3,4-tetrahidr ocarbazol | |
| PT1140794E (pt) | Novo processo de preparacao de aminoacidos quirais | |
| PT89029A (pt) | Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina | |
| DK1017666T3 (da) | Fremgangsmåde til at forøge den optiske renhed af 2R-[1-hydroxy-1-trifluormethyl-3-cyclopropylpropyn-2-yl]-4-chloranilin | |
| BR9507857A (pt) | Um processo para a preparação de derivados de 5,6-Diidroxi-2-amino-1,2,3,4-tetraidronaftaleno | |
| MY117689A (en) | A new process for the preparation of 3-n, n-dicycobutylamino-8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide | |
| DK0778827T3 (da) | Fremgangsmåde til fremstilling af en beta-aminoalkohol | |
| PT882045E (pt) | Processo para a preparacao de granisetron | |
| DK0431305T3 (da) | Fremgangsmåde til fremstilling af molluskicide 2,4,5-tribrompyrrol-3-carbonitriler | |
| GEP19991791B (en) | Pharmacologically Active Enantiomers and Process for its Production | |
| ES2188222T3 (es) | Sintesis enantioselectiva. | |
| ES2140925T3 (es) | Procedimiento para la racemizacion de aminas opticamente activas. | |
| DK0924206T3 (da) | Fremgangsmåde til fremstilling af (R)-3-hydroxy-4-butyrolacton anvendeligt til fremstilling af (R)-carnitin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |